Literature DB >> 18669516

Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus.

Joanne Karen Hobbs1, Keith Miller, Alex John O'Neill, Ian Chopra.   

Abstract

OBJECTIVES: The proposed lethal action of daptomycin on Staphylococcus aureus results from the loss of K(+) and membrane depolarization. However, whether these events alone cause cell death has been questioned. We sought to determine whether other consequences of daptomycin-mediated membrane damage may contribute to cell death.
METHODS: Previously established assays were used to evaluate the membrane damaging activity of daptomycin at a single time-point of 10 min. More detailed time-course experiments were also performed to determine the kinetics of membrane depolarization and leakage of K(+), Mg(2+) and ATP. The kinetics of inhibition of macromolecular synthesis following exposure to daptomycin were also determined by assaying the incorporation of radioactive precursors into macromolecules.
RESULTS: Daptomycin exhibited no membrane damaging activity in single time-point assays following exposure to the antibiotic for 10 min. Kinetic analysis confirmed these results as leakage of intracellular components did not occur until 20-30 min, membrane depolarization was gradual and cells remained biosynthetically active for at least 30 min after exposure to daptomycin. Viability declined rapidly after exposure to daptomycin and appeared to precede other detectable changes.
CONCLUSIONS: These data show that daptomycin-induced loss of Mg(2+) and ATP occurs in conjunction with the previously reported leakage of K(+) and membrane depolarization. We propose that the lethal activity of daptomycin is not simply due to loss of K(+) and probably involves more general damage to the membrane.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669516     DOI: 10.1093/jac/dkn321

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  42 in total

1.  Safety analysis of high dose (>6 mg/kg/day) daptomycin in patients with concomitant statin therapy.

Authors:  J Parra-Ruiz; C Dueñas-Gutiérrez; C Tomás-Jiménez; J P Linares-Palomino; J Garrido-Gomez; J Hernández-Quero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-08       Impact factor: 3.267

2.  Further characterization of Bacillus subtilis antibiotic biosensors and their use for antibacterial mode-of-action studies.

Authors:  Katherine R Mariner; Nicola Ooi; Deborah Roebuck; Alex J O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

3.  Molecular State of the Membrane-Active Antibiotic Daptomycin.

Authors:  Ming-Tao Lee; Wei-Chin Hung; Meng-Hsuan Hsieh; Hsiung Chen; Yu-Yung Chang; Huey W Huang
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

4.  Inhibition of DNA replication in Staphylococcus aureus by tegaserod.

Authors:  Christopher J Lacriola; Shaun P Falk; Bernard Weisblum
Journal:  J Antibiot (Tokyo)       Date:  2017-05-31       Impact factor: 2.649

5.  Plantazolicin is an ultra-narrow spectrum antibiotic that targets the Bacillus anthracis membrane.

Authors:  Katie J Molohon; Patricia M Blair; Seongjin Park; James R Doroghazi; Tucker Maxson; Jeremy R Hershfield; Kristen M Flatt; Nathan E Schroeder; Taekjip Ha; Douglas A Mitchell
Journal:  ACS Infect Dis       Date:  2015-12-23       Impact factor: 5.084

6.  Clinical Mutations That Partially Activate the Stringent Response Confer Multidrug Tolerance in Staphylococcus aureus.

Authors:  Duncan Bryson; Andrew G Hettle; Alisdair B Boraston; Joanne K Hobbs
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

7.  Syntheses and evaluation of macrocyclic engelhardione analogs as antitubercular and antibacterial agents.

Authors:  Li Shen; Marcus M Maddox; Sudip Adhikari; David F Bruhn; Manish Kumar; Robin E Lee; Julian G Hurdle; Richard E Lee; Dianqing Sun
Journal:  J Antibiot (Tokyo)       Date:  2013-04-03       Impact factor: 2.649

8.  Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach.

Authors:  Adrien Fischer; Soo-Jin Yang; Arnold S Bayer; Ali R Vaezzadeh; Sébastien Herzig; Ludwig Stenz; Myriam Girard; George Sakoulas; Alexander Scherl; Michael R Yeaman; Richard A Proctor; Jacques Schrenzel; Patrice François
Journal:  J Antimicrob Chemother       Date:  2011-05-28       Impact factor: 5.790

9.  Evaluation of flavonoid and resveratrol chemical libraries reveals abyssinone II as a promising antibacterial lead.

Authors:  Dianqing Sun; Julian G Hurdle; Robin Lee; Richard Lee; Mark Cushman; John M Pezzuto
Journal:  ChemMedChem       Date:  2012-07-30       Impact factor: 3.466

10.  Daptomycin for methicillin-resistant Staphylococcus epidermidis native-valve endocarditis: a case report.

Authors:  Marylene Duah
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-02-18       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.